Gynecologic Oncology

Gynecol Oncol · ISSN (print) 0090-8258 · ISSN (e) 1095-6859 · 339 papers in corpus
observational 2015
doi:10.1016/j.ygyno.2015.03.058 ·PMID:25868967

OBJECTIVE: To demonstrate the survival impact of intraoperative tumor rupture in women with stage I clear cell carcinoma (CCC) of the ovary. METHODS: A total of 193 patients with stage I CCC of the ovary who had undergone a complete stagin…

rct 2014
doi:10.1016/j.ygyno.2014.08.008 ·PMID:25127988

OBJECTIVE: To determine if an abnormal CA-125 level in a menopausal female without ovarian cancer is associated with an increase in mortality. METHODS: The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Randomized Controlled (PLC…

observational 2014
doi:10.1016/j.ygyno.2014.06.002 ·PMID:24924123

ObjectiveTo describe the study population and estimate overall survival of women with a serous "borderline" ovarian tumor (SBT) in Denmark over 25 years relative to the general population.MethodsThe Danish Pathology Data Bank and the Danish…

review 2014
doi:10.1016/j.ygyno.2014.03.553 ·PMID:24657487

B7-H4 is a transmembrane protein that binds an unknown receptor on activated T cells resulting in inhibition of T-cell effector function via cell cycle arrest, decreased proliferation, and reduced IL-2 production. B7-H4 is up-regulated on t…

observational 2014
doi:10.1016/j.ygyno.2014.03.017 ·PMID:24642093

OBJECTIVE: Endometrioid and clear cell ovarian tumors have been referred to as "endometriosis associated ovarian cancers". However, very few studies have compared clinical and prognostic features of endometriosis-associated cancers or cance…

review 2014
doi:10.1016/j.ygyno.2014.01.012 ·PMID:24440832

OBJECTIVE: The aim of this investigation was to compare outcomes of patients with clear cell carcinoma (CCC) and endometrioid carcinoma (EC) of the ovary associated with endometriosis to patients with ovarian papillary serous carcinoma (PSC…

observational 2014
doi:10.1016/j.ygyno.2014.10.005 ·PMID:25316178

OBJECTIVE: To determine the effect of excisional tubal sterilization on subsequent development of serous epithelial ovarian cancer (EOC) or primary peritoneal cancer (PPC). METHODS: We performed a population-based, nested case-control stud…

review 2014
doi:10.1016/j.ygyno.2014.12.003 ·PMID:25485781

OBJECTIVES: The objective of this review was to discuss the highly variable terminology describing mucinous metaplasia of the endometrium, histologic features and characteristic findings by special stains and immunohistochemistry, different…

review 2014
doi:10.1016/j.ygyno.2013.11.030 ·PMID:24316306

Evidence of a mortality benefit continues to elude ovarian cancer (OC) screening. Data from the US Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial which used a screening strategy incorporating CA125 cut-off and transvag…

observational 2014
doi:10.1016/j.ygyno.2014.08.025 ·PMID:25158036

OBJECTIVE: Pro-inflammatory mechanisms may explain the increased ovarian cancer risk linked to more lifetime ovulations, endometriosis, and exposure to talc and asbestos, as well as decreased risk with non-steroidal anti-inflammatory drugs.…

diagnostic-accuracy 2014
doi:10.1016/j.ygyno.2014.02.026 ·PMID:24582988

AIM: The aim of this study is to validate high-resolution endovaginal T2- and diffusion-weighted MRI measurements (tumour size, volume and length of uninvolved cervical canal) against histology in patients undergoing trachelectomy. PATIENT…

observational 2014
doi:10.1016/j.ygyno.2014.01.026 ·PMID:24462730

OBJECTIVE: To investigate the neutrophil-to-lymphocyte ratio (NLR) from peripheral blood, a general measure of inflammation, in ovarian cancer. METHODS: White cell counts and CA125 levels before treatment, tumor features, and questionnaire…

lab-animal 2014
doi:10.1016/j.ygyno.2014.06.016 ·PMID:24972189

BACKGROUND: Endometriosis is a common condition that is associated with an increased risk of developing ovarian carcinoma. Improved in vitro models of this disease are needed to better understand how endometriosis, a benign disease, can und…

other 2013
doi:10.1016/j.ygyno.2013.05.028 ·PMID:23727327

OBJECTIVES: To develop an assay for anti-HE4 antibodies and assess such antibodies in sera from women with increased epidemiologic risk for ovarian cancer (infertility) and patients with ovarian cancer in comparison to controls. METHODS: A…

observational 2013
doi:10.1016/j.ygyno.2013.02.016 ·PMID:23428461

OBJECTIVE: Preclinical studies suggest that abrupt hormone deprivation caused by oophorectomy, leads to obesity and its metabolic sequelae. The purpose of the current study was to examine the association between oophorectomy and body fatnes…

other 2013
doi:10.1016/j.ygyno.2012.11.021 ·PMID:23178314

OBJECTIVE: Endometrial stromal sarcoma (ESS) and leiomyosarcoma (LMS) are the two most common uterine sarcomas, but both are rare tumors. The aim of the present study was to compare the global gene expression patterns of ESS and LMS. METHO…

review 2013
doi:10.1016/j.ygyno.2012.12.016 ·PMID:23266352

OBJECTIVE: The objective of this article is to broadly review the scientific literature and summarize the most up-to-date findings on ovarian cancer health disparities worldwide and in the United States (U.S.). METHODS: The present literat…

observational 2013
doi:10.1016/j.ygyno.2013.01.027 ·PMID:23385152

OBJECTIVES: To compare the risk of borderline ovarian tumours in women having in vitro fertilization (IVF) with women diagnosed with infertility but not having IVF. METHODS: This was a whole-population cohort study of women aged 20-44 year…

observational 2013
doi:10.1016/j.ygyno.2013.04.469 ·PMID:23648467

OBJECTIVE: To evaluate the effectiveness of definitive involved-field radiation therapy (IFRT) for selected patients with locoregionally-recurrent ovarian cancer. METHODS: We retrospectively reviewed records of 102 epithelial ovarian cance…

observational 2012
doi:10.1016/j.ygyno.2012.08.013 ·PMID:22910690

OBJECTIVE: Epidemiological data indicate that endometriosis increases the risk of epithelial ovarian cancer (EOC), but the mechanism of cancer transition is unknown. Results from genome-wide association studies (GWAS) and transcriptome sequ…

review 2012
doi:10.1016/j.ygyno.2012.04.021 ·PMID:22525820

OBJECTIVE: Different histologic types of epithelial ovarian cancer may represent different diseases with unique clinical and molecular characteristics. Clear cell carcinoma (CCC) of the ovary has been reported as having a worse prognosis th…

lab-animal 2012
doi:10.1016/j.ygyno.2012.06.017 ·PMID:22710073

OBJECTIVES: Cell lines derived from human ovarian and endometrial cancers, and their immortalized non-malignant counterparts, are critical tools to investigate and characterize molecular mechanisms underlying gynecologic tumorigenesis, and …

observational 2012
doi:10.1016/j.ygyno.2011.12.444 ·PMID:22210467

OBJECTIVE: To estimate the incidence of synchronous endometrial cancer (EC) and ovarian cancer (OC) in the female population, among all women with EC, and in women under 50 years of age with EC, and to identify factors associated with synch…

observational 2012
doi:10.1016/j.ygyno.2012.10.023 ·PMID:23116937

OBJECTIVES: To examine the risk of invasive epithelial ovarian cancer in a cohort of women seeking treatment for infertility. METHODS: Using whole-population linked hospital and registry data, we conducted a cohort study of 21,646 women co…

rct 2012
doi:10.1016/j.ygyno.2011.12.440 ·PMID:22198243

OBJECTIVE: To determine whether CA-125 velocity is a statistically significant predictor of ovarian cancer and develop a classification rule to screen for ovarian cancer. METHODS: In the ovarian component of the PLCO cancer screening trial…